Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:TRIL
Delisted

Trillium Therapeutics Inc. Stock Price (Quote)

$18.44
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $18.44 $18.44 Friday, 27th May 2022 TRIL stock ended at $18.44. During the day the stock fluctuated 0% from a day low at $18.44 to a day high of $18.44.
90 days $18.44 $18.44
52 weeks $5.80 $18.49

Historical Trillium Therapeutics Inc. prices

Date Open High Low Close Volume
Jul 08, 2021 $8.52 $8.77 $8.46 $8.63 669 837
Jul 07, 2021 $9.00 $9.07 $8.51 $8.85 742 439
Jul 06, 2021 $9.74 $9.82 $8.95 $8.97 721 111
Jul 02, 2021 $9.89 $9.99 $9.67 $9.70 425 066
Jul 01, 2021 $9.70 $10.02 $9.47 $9.89 824 337
Jun 30, 2021 $9.80 $9.97 $9.57 $9.70 1 165 528
Jun 29, 2021 $10.02 $10.45 $9.77 $9.80 770 282
Jun 28, 2021 $10.59 $10.74 $9.84 $9.98 769 608
Jun 25, 2021 $10.80 $10.90 $10.46 $10.63 12 975 411
Jun 24, 2021 $10.30 $10.91 $10.28 $10.77 1 182 376
Jun 23, 2021 $9.92 $10.39 $9.88 $10.28 745 261
Jun 22, 2021 $10.18 $10.50 $9.81 $9.93 885 405
Jun 21, 2021 $9.78 $10.30 $9.69 $10.17 1 174 532
Jun 18, 2021 $9.88 $9.95 $9.50 $9.81 1 600 796
Jun 17, 2021 $9.47 $9.97 $9.41 $9.93 1 038 240
Jun 16, 2021 $9.34 $9.73 $9.32 $9.51 1 245 603
Jun 15, 2021 $9.77 $9.87 $9.34 $9.42 780 484
Jun 14, 2021 $9.71 $9.92 $9.56 $9.77 841 705
Jun 11, 2021 $9.70 $9.96 $9.55 $9.74 754 526
Jun 10, 2021 $10.11 $10.25 $9.50 $9.70 883 389
Jun 09, 2021 $9.85 $10.34 $9.58 $10.10 1 455 169
Jun 08, 2021 $9.60 $9.71 $9.24 $9.68 1 386 874
Jun 07, 2021 $8.22 $9.74 $8.20 $9.48 3 539 145
Jun 04, 2021 $8.25 $8.34 $8.13 $8.13 500 299
Jun 03, 2021 $8.10 $8.26 $8.05 $8.23 656 191
Click to get the best stock tips daily for free!

About Trillium Therapeutics Inc.

Trillium Therapeutics. Trillium Therapeutics Inc., an immuno-oncology company, develops therapies for the treatment of cancer. The company’s lead program is SIRPaFc, an antibody-like fusion protein, which is in Phase I clinical trial that blocks the activity of CD47 to promote the macrophage-mediated killing of tumor cells in a range of cancers. It also develops CD200 monoclonal antibody that blocks the activity of CD200 to evade attack from the immune system. The com... TRIL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT